The achievements of four East Midlands life science companies have been recognised at the national Medilink UK awards. The Medilink UK awards recognise a variety of outstanding contributions to life sciences, in five different categories. These are Collaboration with the NHS, Export, Innovation, Outstanding Achievement and...
BioCity, the pioneering life science and business collective has announced co-investment into Rinri Therapeutics. A biotechnology company developing a novel cell-based therapy to restore hearing, Rinri Therapeutics have successfully secured £1.4 million in seed funding. BioCity’s recent investment in the biotech company, marks the 28th investment...
Nottingham-based leading DMPK provider, XenoGesis has reported a 78% increase in its exports from last year, with half of its revenue now coming from overseas. Founded in 2011, XenoGesis now has clients across six continents and has experienced consistent growth since day one, with export revenue...
Dr Rachel Hemsley, Global Head of Business Development at Nottingham-based leading DMPK provider XenoGesis, has been appointed to the Advisory Board of BioPartner, the trade organisation for internationalising life sciences companies. BioPartner works closely with UK bioscience sector stakeholders including regional networks, national trade associations, and...
Nottingham-based leading DMPK provider, XenoGesis, has been selected as a CRO partner to support the UK Medicines Discovery Catapult Virtual R&D Discovery Services platform worldwide. Based at BioCity Nottingham, XenoGesis is one of 22 world-class CROs chosen for the partnerships by the UK government’s Medicines Discovery...
BioAscent has been selected as one of the world-class CRO partners tasked with delivering support to the UK Medicines Discovery Catapult’s Virtual R&D Discovery Services platform. The Medicines Discovery Catapult has announced partnerships with a group of leading CROs, with the aim of boosting UK life...
Nottingham, UK – 02 May 2019 BioCity, a pioneering life science incubator and business collective, today announced investment in INCUS Performance, further solidifying their position as a keen investor in promising ventures. Founded in 2016, INCUS Performance is a sports technology start-up that is helping athletes to...
NanoFCM Co., Ltd. today announced that it has established a new facility to support existing and potential users of its Nano-Flow Cytometry platform. The Centre of Excellence is located in MediCity, a biotech incubator in Nottingham, UK. It will allow a close interaction with the...
WASHINGTON—The Department of Homeland Security (DHS) Science and Technology Directorate (S&T) has awarded $1,656,206.00 to Halo X-ray Technologies Ltd (HXT) in Nottingham, UK, to develop and implement an automatic threat resolution system for use with X-ray imaging of carry-on and checked baggage. “The potential use of improvised explosive...
Alderley Park, Cheshire, April 25th. Launching today, Surgical Teaching is a video learning platform for medical students and junior doctors that combines CGI animations, real-life footage and expert narration. This innovative, hybrid approach helps to simplify the learning of complex topics and better prepare users...